PT Pyridam Farma Tbk (PYFA.JK)
IDR 208.0
(-3.7%)
IDR 208.0
(-3.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 702.06 Billion | 715.42 Billion | 630.53 Billion | 277.39 Billion | 247.11 Billion | 250.44 Billion |
| Cost of Revenue | 420.05 Billion | 464.58 Billion | 385.94 Billion | 113.5 Billion | 106.91 Billion | 99.34 Billion |
| Gross Profit | 282.01 Billion | 250.84 Billion | 244.58 Billion | 163.89 Billion | 140.2 Billion | 151.1 Billion |
| Operating Expenses | 293.43 Billion | 255.25 Billion | 193.46 Billion | 132.48 Billion | 129.28 Billion | 137.56 Billion |
| Selling, General and Administrative Expenses | 303.14 Billion | 126.4 Billion | 117.33 Billion | 73.27 Billion | 66.98 Billion | 79.13 Billion |
| Research and Development Expenses | 17.76 Billion | 11.28 Billion | 573.44 Million | - | 5.64 Billion | 853.18 Million |
| Other Expenses | -27.47 Billion | 117.57 Billion | 75.56 Billion | 59.21 Billion | 62.29 Billion | 58.43 Billion |
| Cost and Expenses | 700.18 Billion | 719.83 Billion | 579.41 Billion | 245.99 Billion | 236.19 Billion | 236.9 Billion |
| Operating Income | 1.87 Billion | 345.85 Billion | 51.89 Billion | 32.14 Billion | 15.28 Billion | 14.5 Billion |
| Interest Expense | 86.49 Billion | 79.45 Billion | 41.92 Billion | 2.14 Billion | 2.52 Billion | 2.76 Billion |
| Income Tax Expense | 1.97 Billion | -12.39 Billion | 3.33 Billion | 7.53 Billion | 3.17 Billion | 2.86 Billion |
| Earnings before Tax | -83.24 Billion | 263.08 Billion | 8.81 Billion | 29.64 Billion | 12.51 Billion | 11.31 Billion |
| Net Income | -85.22 Billion | 275.24 Billion | 5.47 Billion | 22.1 Billion | 9.34 Billion | 8.44 Billion |
| Earnings Per Share Basic | -34.20 | 110.44 | 2.20 | 8.87 | 3.75 | 3.16 |
| Earnings Per Share Diluted | -34.20 | 110.44 | 2.20 | 8.87 | 3.75 | 3.16 |
| Weighted Average Shares Outstanding | 2.49 Billion | 2.49 Billion | 2.49 Billion | 2.49 Billion | 2.49 Billion | 2.67 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.49 Billion | 2.49 Billion | 2.49 Billion | 2.49 Billion | 2.49 Billion | 2.67 Billion |
| Gross Margin | 0.40 | 0.35 | 0.39 | 0.59 | 0.57 | 0.60 |
| EBIT Margin | 0.09 | 0.41 | 0.09 | 0.12 | 0.06 | 0.06 |
| Profit Margin | -0.12 | 0.38 | 0.01 | 0.08 | 0.04 | 0.03 |
| EBITDA | 60.69 Billion | 421.42 Billion | 83.73 Billion | 41.27 Billion | 22.72 Billion | 21.81 Billion |
| Earnings Before Tax Margin | 0.00 | 0.48 | 0.08 | 0.12 | 0.06 | 0.06 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 754.5 Billion | 255.68 Billion | 151.63 Billion | 702.06 Billion | 181.59 Billion | 206.86 Billion |
| Cost of Revenue | 617.46 Billion | 167.9 Billion | 92.56 Billion | 420.05 Billion | 112.06 Billion | 120.63 Billion |
| Gross Profit | 137.04 Billion | 87.77 Billion | 59.06 Billion | 282.01 Billion | 69.52 Billion | 86.22 Billion |
| Operating Expenses | 125.76 Billion | 104.7 Billion | 82.12 Billion | 289.71 Billion | 92.48 Billion | 71.74 Billion |
| Selling, General and Administrative Expenses | 121.9 Billion | 99.84 Billion | 37.37 Billion | - | 88.43 Billion | 29.61 Billion |
| Research and Development Expenses | 3.85 Billion | 4.86 Billion | 4.12 Billion | - | 4.05 Billion | 6.03 Billion |
| Other Expenses | -3.85 Billion | -15.52 Billion | 3.33 Billion | 127.77 Million | 7.61 Billion | -1.38 Billion |
| Cost and Expenses | 743.22 Billion | 272.61 Billion | 174.69 Billion | 709.77 Billion | 204.55 Billion | 192.37 Billion |
| Operating Income | 11.28 Billion | -16.93 Billion | -20.41 Billion | -7.7 Billion | -22.95 Billion | 13.05 Billion |
| Interest Expense | 79.72 Billion | 34.01 Billion | 26.39 Billion | 86.49 Billion | 22.58 Billion | 21.41 Billion |
| Income Tax Expense | -10.72 Billion | 10.69 Billion | 1.78 Billion | 1.97 Billion | 2.2 Billion | 853.06 Million |
| Earnings before Tax | -109.76 Billion | -59.18 Billion | -45.31 Billion | -83.24 Billion | -37.51 Billion | -7.95 Billion |
| Net Income | -99.03 Billion | -69.87 Billion | -45.31 Billion | -85.22 Billion | -39.72 Billion | -8.81 Billion |
| Earnings Per Share Basic | -8.81 | -6.22 | -18.18 | - | -15.94 | -3.54 |
| Earnings Per Share Diluted | -8.81 | -6.22 | -18.18 | - | -15.94 | -3.54 |
| Weighted Average Shares Outstanding | 11.23 Billion | 11.23 Billion | 2.49 Billion | 2.49 Billion | 2.49 Billion | 2.49 Billion |
| Weighted Average Shares Outstanding (Diluted) | 11.23 Billion | 11.23 Billion | 2.49 Billion | 2.49 Billion | 2.49 Billion | 2.49 Billion |
| Gross Margin | 0.18 | 0.34 | 0.39 | 0.40 | 0.38 | 0.42 |
| EBIT Margin | -0.04 | -0.07 | -0.10 | - | -0.04 | 0.07 |
| Profit Margin | -0.13 | -0.27 | -0.30 | -0.12 | -0.22 | -0.04 |
| EBITDA | -30.03 Billion | -16.63 Billion | -15.35 Billion | - | -7.47 Billion | 15.36 Billion |
| Earnings Before Tax Margin | 0.01 | -0.07 | -0.13 | -0.01 | -0.13 | 0.06 |
EHMEF
PMDKY
ALNT
M1GU
INNOVATIVE
CMW